Herrera A A - OmicsDI

Show results for

Unknown (5392)
Proteomics (86)
Transcriptomics (51)
Genomics (29)
Metabolomics (15)

Organisms

Schizosaccharomyces pombe (76)
Oryza sativa Indica Group (76)
Sinorhizobium meliloti BL225C (76)
Sus scrofa domesticus (76)
Ostreococcus tauri (76)
Saccharomyces cerevisiae (76)
Staphylococcus aureus (76)
Rattus norvegicus (76)
Escherichia coli (76)
Cyanophora paradoxa (76)
Entamoeba histolytica (76)
Physcomitrium patens (76)
Methylohalobius crimeensis 10Ki (76)
Homo sapiens (76)
Lotus japonicus (76)
Shigella flexneri (76)
Ctenopharyngodon idella (76)
Danio rerio (76)
Allexis (76)
Shigella (76)
Homo sapiens (29)
Mus musculus (13)
Arabidopsis thaliana (5)
Saccharomyces cerevisiae (2)
Rattus norvegicus (2)
Plasmodium vivax (1)
Zea mays (1)
Carica papaya (1)
Panulirus argus (1)
Eptesicus fuscus (1)

Organisms

Homo sapiens (3)
Musonycteris harrisoni (2)
Leptonycteris nivalis (2)
Amphiprion ocellaris (1)
Acanthurus triostegus (1)
Scyliorhinus canicula (1)
Trichoderma atroviride (1)
Artibeus jamaicensis (1)
Mus musculus (1)

Repository

pride (76)
biostudies-arrayexpress (54)
ENA (26)
MetaboLights (14)
MassIVE (6)
iProX (2)
PanoramaPublic (2)
GNPS (1)

Tissue

Epithelial cell (14)
Cell culture (10)
Lung (7)
Fibroblast (3)
Permanent cell line cell (3)
Blood plasma (2)
Embryo (2)
Colon (2)
Blood (2)
Endometrial cancer cell line (1)
Pancreatic endocrine cell (1)
Peritoneal fluid (1)
Peritoneal exudate (1)
Systemic vein (1)
SW-620 cell (1)
MiaPaCa-2 cell (1)
Colorectal adenocarcinoma cell line (1)
Lung epithelium (1)
Nucleus pulposus cell of intervertebral disc (1)
Intervertebral disc (1)
Pancreatic cancer cell line (1)
Serum (1)
Natural killer cell (1)
Stomach (1)
Breast (1)
Pancreas (1)
Melanocyte (1)
Embryonic stem cell (1)
Urine (1)
Skin (1)

Disease

Colon cancer (15)
Idiopathic pulmonary fibrosis (4)
Skin melanoma (2)
Pancreatic ductal adenocarcinoma (2)
Malignant neoplasm of ovary (2)
Breast cancer (2)
Disease free (2)
Breast carcinoma (1)
Intracerebral hemorrhage (1)
Prediabetes syndrome (1)
Lung non-squamous non-small cell carcinoma (1)
Septicemia (1)
Coronavirus infectious disease (1)
Diabetes mellitus (1)
Stomach cancer (1)
Endometrial cancer (1)
Lung adenocarcinoma (1)
Gastric adenocarcinoma (1)
Systemic lupus erythematosus (1)
Cervix carcinoma (1)
Pancreatic cancer (1)
Degenerative disc disease (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (76)
Shotgun proteomics (30)
Mass spectrometry (13)
Bottom-up proteomics (13)
Affinity purification coupled with mass spectrometry proteomics (13)
Data-dependent acquisition (9)
SWATH MS (6)
Gel-based experiment (6)
Data-independent acquisition (3)
Mass spectrometry assay (1)
All-ion fragmentation (1)
HDMSE (1)
SRM/MRM (1)
Top-down proteomics (1)

Instrument Platform

Orbitrap Fusion (3)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (3)
Gas Chromatography MS - positive (3)
Bio-Rad CFX96 Real-time System (2)
Illumina HiSeq 4000 (2)
NextSeq 500 (2)
Diode array detection MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Nikon Eclipse Ti2 with brightfield and fluorescence capacity (TRITC) (1)
Leica Biosystems Cryostat (1)
BD LSRFortessa (1)
MACS Whole Skin Dissociation Kit (1)
Illumina Genome Analyzer IIx (1)
Orbitrap Exploris 120 (1)
TripleTOF 6600 (1)
Orbitrap Exploris 240 (1)
Q Exactive Plus (1)
Orbitrap Fusion Lumos (1)
MaXis (Bruker) (1)
SYNAPT HDMS (Waters) (1)
Gas Chromatography MS - (1)
Exactive (Thermo Scientific) (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (18)
2019 (16)
2023 (13)
2021 (12)
2016 (12)
2022 (11)
2026 (9)
2014 (9)
2024 (9)
2015 (8)
2020 (6)
2010 (5)
2018 (5)
2013 (4)
2012 (4)
2011 (4)
2009 (4)
2017 (3)

CHEBI ID

CHEBI:23401 (3)
CHEBI:17580 (3)
CHEBI:16188 (3)
CHEBI:22469 (3)
CHEBI:17447 (3)
CHEBI:28527 (3)
CHEBI:66395 (3)
CHEBI:17521 (3)
CHEBI:87393 (3)
CHEBI:30776 (3)
CHEBI:15756 (3)
CHEBI:177384 (2)
CHEBI:156100 (2)
CHEBI:28913 (2)
CHEBI:34118 (2)
CHEBI:145715 (2)
CHEBI:145096 (2)
CHEBI:43003 (2)
CHEBI:144070 (2)
CHEBI:64634 (2)
CHEBI:145829 (2)
CHEBI:76137 (2)
CHEBI:76116 (2)
CHEBI:88900 (2)
CHEBI:50462 (2)
CHEBI:64621 (2)
CHEBI:76173 (2)
CHEBI:75630 (2)
CHEBI:87510 (2)
CHEBI:31018 (2)

Metabolite Name

Geraniol (3)
Coumaric acid (3)
Linalool (3)
1-Octen-3-ol (3)
Hexanoic acid (3)
Rutin (3)
(E)-2-Pentenal (2)
(E)-2-Octenal (2)
(E)-2-Hexenal (2)
(E)-2-Heptenal (2)
Octanol (2)
Nonanol (2)
3-Hexenol (2)
2-Hexenol (2)
Hexanol (2)
Heptanol (2)
Nerol (2)
Kaempferol O-glucoside (2)
Quercetin O-glucuronide (2)
Quercetin O-glucoside (2)
Procyanidin B3 (2)
Trilobatin (2)
Catechin condensation product (2)
(+)-trans-epsilon-viniferin (2)
(2R,3S)-trans-coutaric acid (2)
(2R,3R)-trans-fertaric acid (2)
(2S,3R)-trans-caftaric acid (2)
Methyl gallate (2)
1-Octen-3-one (2)
Citronellol (2)

First Public Date

2020 (7)
2026 (4)
2024 (3)
2023 (3)
2022 (3)
2025 (2)
2019 (2)
2021 (1)
2013 (1)

Study type

Transcription profiling by array (35)
RNA-seq of coding RNA (9)
Transcription profiling by RT-PCR (2)
ChIP-seq (2)
ChIP-chip by tiling array (1)
Genotyping by array (1)
Spatial transcriptomics by high-throughput sequencing (1)
Comparative genomic hybridization by array (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (716)
2025 (662)
2021 (649)
2023 (625)
2024 (556)
2020 (472)
2019 (353)
2018 (290)
2017 (201)
2016 (201)
2015 (156)
2014 (112)
2026 (83)
2013 (74)
2012 (65)
2011 (58)
2010 (50)
2009 (47)
2008 (22)
2005 (14)
2006 (12)
2007 (10)
2003 (5)
2004 (3)
2002 (3)
1998 (3)
2001 (2)
1996 (1)

Lab affiliation

Core Facility for Medical Bioanalytics Proteomics Platform Tübingen (PxP) Institute for Ophthalmic Research Eberhard-Karls University of Tuebingen Elfriede-Aulhorn-Str. 7 D-72076 Tuebingen. Germany. (7)
Cancer Biology Department, Fox Chase Cancer Center, Philadelphia, PA, USA (2)
The Wellcome Centre for Cell-Matrix Research, University of Manchester, Manchester, UK (2)
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel (2)
Universidad Andrés Bello, Laboratorio de Patología de Organismos Acuáticos y Biotecnología Acuícola, Facultad de Ciencias de la Vida, Viña del Mar, Chile (2)
Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, M13 9PT (2)
Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0379 Oslo, Norway (2)
CEA-Marcoule, ProGenoMIX platform, DRF-Li2D, 30207 Bagnols-sur-Ceze, France (2)
Functional Proteomics, ICR (2)
Core Facility for Medical Bioanalytics Proteomics Platform Tübingen (PxP) Institute for Ophthalmic Research Eberhard-Karls University of Tuebingen Elfriede-Aulhorn-Str. 7 D-72076 Tuebingen. Germany (1)
Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK. (1)
Wellcome Centre for Cell-Matrix Research, Division of Molecular and Cellular Function, University of Manchester, UK (1)
Professor of Molecular Biology, University of Dundee (1)
Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM/ Dirección General, Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, 1450 Tlalpan, Ciudad de México (1)
Medical Oncology Service, Hospital Universitario La Paz-IdiPAZ, Madrid (1)
Universidad Nacional Autonoma de Mexico, Facultad de Quimica (1)
Center of Genomics Sciences/National Autonomous University of Mexico (1)
Proteomics Laboratory CSIC/UAB, Institut d’Investigacions Biomèdiques de Barcelona (IIBB-CSIC-IDIBAPS), Barcelona, Spain. (1)
Proteomics Unit Navarrabiomed (1)
Medical Research Council - London Institute of Medical Sciences, Telomere Replication and Stability Group, United Kingdom. (1)
Cancer Biology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States (1)
Institut Mondor de Recherche Biomédicale, INSERM, U955, 94010 Créteil, France Université Paris Est Créteil, 94010, Créteil, France (1)
The Insitute of Cancer Research (1)
Laboratorio de Biología Molecular Departamento de Fibrosis Pulmonar Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" (INER). Ciudad de México (1)
Vascular Biology and Inflammation (1)
Programa de Genómica Funcional de Procariontes, Centro de Ciencias Genómicas-UNAM. Av. Universidad s/n, Col. Chamilpa, Cuernavaca, Morelos. CP 62210. México. (1)
Instituto de Invesstigaciones Sanitarias de Santiago de Compostela (1)
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany Gene and RNA Therapy Center (GRTC), Faculty of Medicine, University of Tübingen, Tübingen, Germany iFIT Cluster of Excellence (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany (1)
Proteomics Facility and Metabolomics Facility 139 Biotechnology Building, Cornell University 526 Campus Road, Ithaca, NY 14853 (1)
Department of Cellular and Molecular Pharmacology University of California San Francisco (UCSF) San Francisco, CA 94158 USA (1)

Previous page
1 / 558
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 558
Next page

Sort by:

Relevance

Page size

Discovery of A-type procyanidin dimers in yellow raspberries by untargeted metabolomics and correlation based data analysis

Introduction:Raspberries are becoming increasingly popular due to their reported health beneficial properties. Despite the presence of only trace amounts of anthocyanins yellow varieties seems to show similar or better effects in comparison to conventional raspberries.Objectives:The a...

2016-08-23 | MTBLS333 | MetaboLights

Effects of neuromuscular training compared to classic strength-resistance training in patients with acute coronary syndrome: A study protocol for a randomized controlled trial.

Not available

S-EPMC7757882 | biostudies-literature

HPE1, an Effector from Zebra Chip Pathogen Interacts with Tomato Proteins and Perturbs Ubiquitinated Protein Accumulation.

Not available

S-EPMC8396652 | biostudies-literature

A novel (targeted) kinesio taping application on chronic low back pain: Randomized clinical trial.

Not available

S-EPMC8118519 | biostudies-literature

Exploring the Prevalence of Antimicrobial Resistance in Salmonella and commensal Escherichia coli from Non-Traditional Companion Animals: A Pilot Study.

Not available

S-EPMC10889945 | biostudies-literature

Prepulse Inhibition in Cocaine Addiction and Dual Pathologies.

Not available

S-EPMC7924364 | biostudies-literature

Time-Course Changes in Oxidative Stress and Inflammation in the Retinas of rds Mice: A Retinitis Pigmentosa Model.

Not available

S-EPMC9598580 | biostudies-literature

Lasting consequences of psyllid (Bactericera cockerelli L.) infestation on tomato defense, gene expression, and growth.

Not available

S-EPMC7905647 | biostudies-literature

Epidemiology, clinical and pathological features and outcomes of listeriosis in ruminants: a systematic review and meta-analysis.

Not available

S-EPMC12690773 | biostudies-literature

MaHPIC Experiment HuC - Metabolomics of plasma samples from human volunteers infected with Plasmodium vivax

Project Description:
The Malaria Host-Pathogen Interaction Center (MaHPIC) is a transdisciplinary malaria systems biology research program initially supported by an NIH/NIAID contract (HHSN272201200031C, 2012-2017; see http://w...

2018-06-19 | MTBLS665 | MetaboLights

Previous page
1 / 558
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 558
Next page

Sort by:

Relevance

Page size

5573 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets